1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > Global Nuclear Medicine Radioisotopes Market - Analysis and Forecasts (2015-2020)

The global market for Radioisotopes is estimated to be valued as $9.61 billion in 2015 and is expected to reach $17.28 billion by the end of 2020. During this period of forecast the market is expected to grow at a CAGR of 12.45%.

Major driving factors for the growth of the market are increasing demand of SPECT analysis in radiopharmaceuticals, development of better instruments, newer computer based procedures for image analysis and display, new 99mTc labeled agents for visualizing biologically significant events, increasing demand of PET analysis in radiopharmaceuticals, increasing use in clinical applications to study psychiatric disorders. Integration of X ray tomography (CT) into SPECT has recently emerged as a brilliant diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. . However, some of the major constrains for the market are shorter half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues.

SPECT radioisotopes chemical form of thallous chloride has been the principle tracer used in myocardial perfusion imaging. Technetium-99m is the major radioisotope used in SPECT. Generally technetium is produced in technetium generators.Tl-201 is used in myocardial perfusion studies, In-111 is used in prostate cancer, and Ga-67 is used in lymphoma diagnosis and treatment. The most commonly used radiotracer in PET imaging is F-18 fluorodeoxyglucose (FDG), a glucose analogue. FDG-PET scans have been very accurate than conventional imaging in evaluation of many malignancies. The other radionuclide used is Rubidium-82.

PET imaging radioisotopes has got many applications in clinical neurology which involves movement disorders, epilepsy, brain tumors, dementia, Stroke and neuronal plasticity etc. Future applications include early diagnosis of brain metastases, Parkinson syndromes and neurodegenerative disorders such as AD. Market for radioisotopes is expected to be more in developing countries because of increasing awareness of people for radioisotopes, increasing incidence of chronic disease like cancer and increasing population.

Market is segmented by type of radioisotopes (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123), Fluorine-18, Rubidium-82 (RB-82) and others). By application market is segmented into (cardiology, lymphoma, thyroid, neurology oncology, and others).By geography market is segmented into North America, Europe and Asia-Pacific etc.

Major players in the market GE Healthcare, Hologic Inc., Medix Inc., Naviscan Inc., Positron Corporation, Segami Corporation. Mergers and acquisitions of small and medium sized manufacturers to enter in overseas market is a strategy adopted by multinational players.

What the Report Offers
1) Market Definition Global nuclear medicine radioisotopes market along with identification of key drivers and restraints for the market.
2) Market analysis for the Global nuclear medicine radioisotopes market with region specific assessments and competition analysis on a global and regional scale.
3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4) Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
5) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Reasons for Buying this Report
1) For gaining an exhaustive understanding of the worldwide market for Global nuclear medicine radioisotopes market. Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
2) An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.
3) Wide-ranging information provided about the leading market players and the major strategies adopted by them.

Table Of Contents

Global Nuclear Medicine Radioisotopes Market - Analysis and Forecasts (2015-2020)
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Technology Overview
5.3 New Developments
5.4 Industry Value-Chain Analysis
5.5 Product Life-Cycle Analysis
5.6 Product Benchmarking
5.7 Investment Analysis
5.8 Porter's Five Forces
5.8.1 Bargaining Power of Suppliers
5.8.2 Bargaining Power of Consumers
5.8.3 Threat of New Entrants
5.8.4 Threat of Substitute Products and Services
5.8.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising incidences of Cancer and Cardiac disorders
6.1.2 Development of better instruments
6.1.3 Increasing SPECT and PET applications
6.1.4 Growing Patient awareness
6.2 Market Restraints
6.2.1 Strict Regulatory Issues
6.2.2 Reimbursement Problems
6.2.3 Declining Trends in FDA Pharmacotherapy Approval rate
6.3 Key Challenges
6.4 Current Opportunities in the Market
6.4.1 Increasing Imaging Technologies
6.4.2 Potential Radioisotopes in pipeline
6.4.3 Increasing neurological applications
6.4.4 Cyclotron based production
7. Market Segmentation
7.1 By Type of Radioisotopes
7.1.1 Technetium-99m (Tc-99m)
7.1.2 Thallium-201 (Tl-201)
7.1.3 Iodine (I-123)
7.1.4 Fluorine-18
7.1.5 Rubidium-82 (Rb-82)
7.1.6 Iodine-131 (I-131)
7.1.7 Yttrium-90 (Y-90)
7.1.8 Samarium-153 (Sm-153)
7.1.9 Rhenium-186 (Re-186)
7.1.10 Lutetium-177 (Lu-177)
7.1.11 Radium-223 (Ra-223) and Alpharadin
7.1.12 Actinium-225 (Ac-225)
7.1.13 Lead-212 (Pb-212)/Bismuth-212 (Bi-212)
7.1.14 Astatine-211 (At-211)
7.1.15 Radium-224 (Ra-224)
7.1.16 Thorium-227 (Th-227)
7.1.17 Cesium-131
7.1.18 Iodine-125
7.1.19 Palladium-103
7.1.20 Iridium-192
7.1.21 Others
7.2 By Application
7.2.1 Oncology
7.2.2 Cardiology
7.2.3 Lymphoma
7.2.4 Thyroid
7.2.5 Neurology
7.2.6 Others
7.3 By Geography
7.3.1 North America (NA) United States Canada Mexico
7.3.2 Europe Germany UK France Italy Spain and Portugal Scandinavia BENELUX
7.3.3 Asia-Pacific (APAC) China Japan India Australia and New Zealand South Korea
7.3.4 Middle-East and Africa (MEA) GCC Egypt Sudan Morocco Algeria
7.3.5 Latin America Brazil Argentina Colombia Chile Peru Venezuela
8. Competitive Landscape
8.1 Mergers and Acquisitions
8.2 New Product Launches
8.3 Agreements, Collaborations and Partnerships
9. Key Vendor Analysis
10. Analyst Outlook for Investment Opportunities
11. Future Outlook of the Market

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global small animal imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is projected to be valued at USD 910.4 million by 2021. Market growth in the global small animal ...

Global Nuclear Medicine Diagnostics Market (SPECT and PET ) - Analysis and Forecasts (2015-2020)

Global Nuclear Medicine Diagnostics Market (SPECT and PET ) - Analysis and Forecasts (2015-2020)

  • $ 4 250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global Nuclear Medicine Market is expected to reach USD 17,600 million by the end of 2019 growing at a CAGR of around 12.29% from 2014 to 2019. Nuclear Medicine utilizes the radioisotope for application ...

Global Nuclear Imaging Market

Global Nuclear Imaging Market

  • $ 4 250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global nuclear medicine diagnostic (PET and SPECT) market is expected to grow from an estimated $ 8.77 billion in 2014 to $ 15.51 billion in 2019, at an estimated compound annual growth rate (CAGR) ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.